Tom R. Fitch
- Oncology top 1%
- Cancer Treatment and Pharmacology 26
- Colorectal Cancer Treatments and Studies 17
- HER2/EGFR in Cancer Research 9
- Lung Cancer Research Studies 9
- Pancreatic and Hepatic Oncology Research 8
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 8
- Hepatology top 2%
-
- Lung Cancer Treatments and Mutations 17
- Renal cell carcinoma treatment 7
- Co-authors
- Kendrith M. RowlandCharles ErlichmanShaker R. DakhilHenry C. PitotJeff A. SloanMichelle R. MahoneyJoel PicusPaul J. Novotny
- Cited by
- OncologyCancer ResearchHepatology
- Partner nations
- United StatesCanadaBelarus
In The Last Decade
Tom R. Fitch
96 papers receiving 4.5k citations
Peers
Comparison fields: 5 of 121
- Oncology 2.0k
- Cancer Research 813
- Hepatology 407
- Pulmonary and Respiratory Medicine 1.3k
- Pathology and Forensic Medicine 652
Countries citing papers authored by Tom R. Fitch
This map shows the geographic impact of Tom R. Fitch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom R. Fitch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom R. Fitch more than expected).
Fields of papers citing papers by Tom R. Fitch
This network shows the impact of papers produced by Tom R. Fitch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom R. Fitch. The network helps show where Tom R. Fitch may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tom R. Fitch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2015 | 14 | |
| 3 | 2014 | 16 | |
| 4 | 2012 | 6 | |
| 5 | 2012 | 43 | |
| 6 | 2011 | 15 | |
| 7 | 2010 | 40 | |
| 8 | 2010 | 79 | |
| 9 | 2009 | 48 | |
| 10 | 2006 | 86 | |
| 11 | 2006 | 1 | |
| 12 | 2006 | 132 | |
| 13 | 2005 | 52 | |
| 14 | 2005 | 18 | |
| 15 | 2004 | 26 | |
| 16 | 2003 | 6 | |
| 17 | 2003 | 31 | |
| 18 | 2003 | 36 | |
| 19 | 2000 | 13 | |
| 20 | 1999 | 26 |
About Tom R. Fitch
Tom R. Fitch is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 97 papers that have together received 4.6k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (26 papers), Lung Cancer Treatments and Mutations (17 papers), Colorectal Cancer Treatments and Studies (17 papers), HER2/EGFR in Cancer Research (9 papers), Lung Cancer Research Studies (9 papers), Pancreatic and Hepatic Oncology Research (8 papers), Cancer Genomics and Diagnostics (8 papers) and Renal cell carcinoma treatment (7 papers). The work is most often cited by research in Oncology (2.0k citations), Cancer Research (813 citations) and Hepatology (407 citations). Tom R. Fitch has collaborated with scholars based in United States, Canada and Belarus. Frequent co-authors include Kendrith M. Rowland, Charles Erlichman, Shaker R. Dakhil, Henry C. Pitot, Jeff A. Sloan, Michelle R. Mahoney, Joel Picus, Paul J. Novotny, Charles L. Loprinzi and Philip A. Philip.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.